These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 31594558)

  • 21. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation and in vitro study of buagafuran solid dispersions].
    Xia XJ; Tao ZH; Ren Y; Wang RY; Liu YL
    Yao Xue Xue Bao; 2008 May; 43(5):548-52. PubMed ID: 18717346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The application of solid dispersion technique in the preparation of therapeutic tablets. Part 1: Paracetamol, amylobarbitone, and caffeine tablets.
    El-Banna HM; Eshra AG; Hammouda Y
    Pharmazie; 1977; 32(8-9):511-5. PubMed ID: 145597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique.
    Chauhan B; Shimpi S; Paradkar A
    AAPS PharmSciTech; 2005 Oct; 6(3):E405-12. PubMed ID: 16353998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization and Pharmacokinetic Study of Aprepitant Solid Dispersions with Soluplus®.
    Liu J; Zou M; Piao H; Liu Y; Tang B; Gao Y; Ma N; Cheng G
    Molecules; 2015 Jun; 20(6):11345-56. PubMed ID: 26102068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanisms of drug release from solid dispersions in water-soluble polymers.
    Craig DQ
    Int J Pharm; 2002 Jan; 231(2):131-44. PubMed ID: 11755266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase separation kinetics in amorphous solid dispersions upon exposure to water.
    Purohit HS; Taylor LS
    Mol Pharm; 2015 May; 12(5):1623-35. PubMed ID: 25853391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone.
    Tantishaiyakul V; Kaewnopparat N; Ingkatawornwong S
    Int J Pharm; 1999 Apr; 181(2):143-51. PubMed ID: 10370210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound influence on the solubility of solid dispersions prepared for a poorly soluble drug.
    Pereira SV; Colombo FB; de Freitas LA
    Ultrason Sonochem; 2016 Mar; 29():461-9. PubMed ID: 26548840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase behavior of amorphous molecular dispersions II: Role of hydrogen bonding in solid solubility and phase separation kinetics.
    Vasanthavada M; Tong WQ; Joshi Y; Kislalioglu MS
    Pharm Res; 2005 Mar; 22(3):440-8. PubMed ID: 15835750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30.
    Damian F; Blaton N; Kinget R; Van den Mooter G
    Int J Pharm; 2002 Sep; 244(1-2):87-98. PubMed ID: 12204568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the pharmacokinetic profiles of soluble aspirin and solid paracetamol tablets in fed and fasted volunteers.
    Stillings M; Havlik I; Chetty M; Clinton C; Schall R; Moodley I; Muir N; Little S
    Curr Med Res Opin; 2000; 16(2):115-24. PubMed ID: 10893655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systems biology approach to study permeability of paracetamol and its solid dispersion.
    Khan S; Elshaer A; Rahman AS; Hanson P; Perrie Y; Mohammed AR
    Int J Pharm; 2011 Sep; 417(1-2):272-9. PubMed ID: 21187133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions.
    Thiry J; Broze G; Pestieau A; Tatton AS; Baumans F; Damblon C; Krier F; Evrard B
    Eur J Pharm Sci; 2016 Mar; 85():94-105. PubMed ID: 26850682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of 19F-NMR for assessing the molecular mobility of flufenamic acid in solid dispersions.
    Aso Y; Yoshioka S; Miyazaki T; Kawanishi T
    Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):61-4. PubMed ID: 19122317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
    Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
    Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Miscibility of nifedipine and hydrophilic polymers as measured by (1)H-NMR spin-lattice relaxation.
    Aso Y; Yoshioka S; Miyazaki T; Kawanishi T; Tanaka K; Kitamura S; Takakura A; Hayashi T; Muranushi N
    Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1227-31. PubMed ID: 17666850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic investigation of Pluronic based nano-crystalline drug-polymer solid dispersions.
    Qian F; Tao J; Desikan S; Hussain M; Smith RL
    Pharm Res; 2007 Aug; 24(8):1551-60. PubMed ID: 17380258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.